Comparison of inhibitory effects of glucosamine and mannosamine on bovine articular cartilage degradation in vitro

David M. Mello Department of Animal Science, College of Agriculture and Natural Resources, Michigan State University, East Lansing, MI 48824.

Search for other papers by David M. Mello in
Current site
Google Scholar
PubMed
Close
 MS
,
Brian D. Nielsen Department of Animal Science, College of Agriculture and Natural Resources, Michigan State University, East Lansing, MI 48824.

Search for other papers by Brian D. Nielsen in
Current site
Google Scholar
PubMed
Close
 PhD
,
Tonia L. Peters Department of Animal Science, College of Agriculture and Natural Resources, Michigan State University, East Lansing, MI 48824.

Search for other papers by Tonia L. Peters in
Current site
Google Scholar
PubMed
Close
 MS
,
John P. Caron Department of Large Animal Clinical Sciences, College of Veterinary Medicine, Michigan State University, East Lansing, MI 48824.

Search for other papers by John P. Caron in
Current site
Google Scholar
PubMed
Close
 DVM
, and
Michael W. Orth Department of Animal Science, College of Agriculture and Natural Resources, Michigan State University, East Lansing, MI 48824.

Search for other papers by Michael W. Orth in
Current site
Google Scholar
PubMed
Close
 PhD

Abstract

Objective—To compare the inhibitory effects of glucosamine and mannosamine on articular cartilage degradation and the effects on chondrocyte viability in vitro.

Sample Population—Bovine articular cartilage explants.

Procedures—Explants were cultured in commercial medium for 48 hours. Cartilage was exposed to medium containing 10% fetal bovine serum, 10 µg of lipopolysaccharide/mL, and 0.5, 1.0, 2.5, 5.0, and 10.0 mg of glucosamine or mannosamine/mL for 24 hours. Nitric oxide (NO) production (nitrite concentration) and proteoglycan (PG) release (PG concentration) in media were measured . Cartilage extracts were analyzed via zymography to detect gelatinolytic activity. At the end of the experiment, explants were assessed for chondrocyte viability.

Results—Addition of lipopolysaccharide resulted in increased NO production and PG release, but no increase in gelatinolytic activity, compared with controls. Glucosamine and mannosamine at concentrations as low as 0.5 mg/mL inhibited NO production. Glucosamine inhibited PG release at a minimum concentration of 1.0 mg/mL, whereas mannosamine inhibited PG release at a concentration of 0.5 mg/mL. Concentrations of glucosamine ≤ 5.0 mg/mL did not adversely affect chondrocyte viability; however, at a concentration of 10.0 mg/mL, cell death was evident. Mannosamine had a toxic effect at a concentration of 5.0 mg/mL and was associated with pronounced chondrocyte death at a concentration of 10.0 mg/mL.

Conclusions and Clinical Relevance—Glucosamine and mannosamine inhibit selected indices of bovine articular cartilage degradation at concentrations that do not affect chondrocyte viability. The potential for cytotoxic effects at higher concentrations underscores the importance of establishing appropriate dosage regimens for these aminomonosaccharides. (Am J Vet Res 2004;65:1440–1445)

Abstract

Objective—To compare the inhibitory effects of glucosamine and mannosamine on articular cartilage degradation and the effects on chondrocyte viability in vitro.

Sample Population—Bovine articular cartilage explants.

Procedures—Explants were cultured in commercial medium for 48 hours. Cartilage was exposed to medium containing 10% fetal bovine serum, 10 µg of lipopolysaccharide/mL, and 0.5, 1.0, 2.5, 5.0, and 10.0 mg of glucosamine or mannosamine/mL for 24 hours. Nitric oxide (NO) production (nitrite concentration) and proteoglycan (PG) release (PG concentration) in media were measured . Cartilage extracts were analyzed via zymography to detect gelatinolytic activity. At the end of the experiment, explants were assessed for chondrocyte viability.

Results—Addition of lipopolysaccharide resulted in increased NO production and PG release, but no increase in gelatinolytic activity, compared with controls. Glucosamine and mannosamine at concentrations as low as 0.5 mg/mL inhibited NO production. Glucosamine inhibited PG release at a minimum concentration of 1.0 mg/mL, whereas mannosamine inhibited PG release at a concentration of 0.5 mg/mL. Concentrations of glucosamine ≤ 5.0 mg/mL did not adversely affect chondrocyte viability; however, at a concentration of 10.0 mg/mL, cell death was evident. Mannosamine had a toxic effect at a concentration of 5.0 mg/mL and was associated with pronounced chondrocyte death at a concentration of 10.0 mg/mL.

Conclusions and Clinical Relevance—Glucosamine and mannosamine inhibit selected indices of bovine articular cartilage degradation at concentrations that do not affect chondrocyte viability. The potential for cytotoxic effects at higher concentrations underscores the importance of establishing appropriate dosage regimens for these aminomonosaccharides. (Am J Vet Res 2004;65:1440–1445)

Advertisement